A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
- PMID: 7509044
- DOI: 10.1038/367645a0
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Abstract
Most human acute myeloid leukaemia (AML) cells have limited proliferative capacity, suggesting that the leukaemic clone may be maintained by a rare population of stem cells. This putative leukaemic stem cell has not been characterized because the available in vitro assays can only detect progenitors with limited proliferative and replating potential. We have now identified an AML-initiating cell by transplantation into severe combined immune-deficient (SCID) mice. These cells homed to the bone marrow and proliferated extensively in response to in vivo cytokine treatment, resulting in a pattern of dissemination and leukaemic cell morphology similar to that seen in the original patients. Limiting dilution analysis showed that the frequency of these leukaemia-initiating cells in the peripheral blood of AML patients was one engraftment unit in 250,000 cells. We fractionated AML cells on the basis of cell-surface-marker expression and found that the leukaemia-initiating cells that could engraft SCID mice to produce large numbers of colony-forming progenitors were CD34+ CD38-; however, the CD34+ CD38+ and CD34- fractions contained no cells with these properties. This in vivo model replicates many aspects of human AML and defines a new leukaemia-initiating cell which is less mature than colony-forming cells.
Similar articles
-
Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia.Blood. 2001 Jun 15;97(12):3882-9. doi: 10.1182/blood.v97.12.3882. Blood. 2001. PMID: 11389030
-
Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice.Blood. 1996 Oct 1;88(7):2655-64. Blood. 1996. PMID: 8839860
-
Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells.Blood. 1999 Jul 15;94(2):529-38. Blood. 1999. PMID: 10397720
-
Immunophenotypic features of early haematopoietic and leukaemia stem cells.Int J Lab Hematol. 2024 Oct;46(5):795-808. doi: 10.1111/ijlh.14348. Epub 2024 Jul 24. Int J Lab Hematol. 2024. PMID: 39045906 Review.
-
Leukemia stem cells: Old concepts and new perspectives.Mol Aspects Med. 2014 Oct;39:102-9. doi: 10.1016/j.mam.2013.06.003. Epub 2013 Jun 29. Mol Aspects Med. 2014. PMID: 23820118 Free PMC article. Review.
Cited by
-
Clinical and Biological Implications of Cancer Stem Cells in Hepatocellular Carcinoma.Yonago Acta Med. 2021 Jan 6;64(1):1-11. doi: 10.33160/yam.2021.02.002. eCollection 2021 Feb. Yonago Acta Med. 2021. PMID: 33642898 Free PMC article. Review.
-
The Polo-Like Kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemia.PLoS One. 2013;8(3):e58424. doi: 10.1371/journal.pone.0058424. Epub 2013 Mar 8. PLoS One. 2013. PMID: 23520509 Free PMC article. Clinical Trial.
-
Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors.J Clin Invest. 2013 Jan;123(1):315-28. doi: 10.1172/JCI64180. Epub 2012 Dec 3. J Clin Invest. 2013. PMID: 23202731 Free PMC article. Clinical Trial.
-
Overcoming Treatment Resistance in Medulloblastoma: Underlying Mechanisms and Potential Strategies.Cancers (Basel). 2024 Jun 18;16(12):2249. doi: 10.3390/cancers16122249. Cancers (Basel). 2024. PMID: 38927954 Free PMC article. Review.
-
Identification and Characterization of CXCR4-Positive Gastric Cancer Stem Cells.PLoS One. 2015 Jun 25;10(6):e0130808. doi: 10.1371/journal.pone.0130808. eCollection 2015. PLoS One. 2015. PMID: 26110809 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials